These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10049445)

  • 21. The rationale for screening and surveillance of Barrett's metaplasia.
    Wani S; Sharma P
    Best Pract Res Clin Gastroenterol; 2006; 20(5):829-42. PubMed ID: 16997164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Barrett's esophagus: diagnosis and therapy].
    Schmassmann A; Gebbers JO
    Praxis (Bern 1994); 2005 May; 94(21):861-8. PubMed ID: 15966485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
    Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
    Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus.
    Li X; Paulson TG; Galipeau PC; Sanchez CA; Liu K; Kuhner MK; Maley CC; Self SG; Vaughan TL; Reid BJ; Blount PL
    Cancer Prev Res (Phila); 2015 Sep; 8(9):845-56. PubMed ID: 26130253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond Dysplasia Grade: The Role of Biomarkers in Stratifying Risk.
    Dunbar KB; Souza RF
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):447-459. PubMed ID: 28577766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention].
    Peitz U; Malfertheiner P
    Z Gastroenterol; 2007 Dec; 45(12):1264-72. PubMed ID: 18080229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced Endoluminal Technologies for Barrett's Esophagus: Focus on Optical Coherence Tomography and Confocal Laser Endomicroscopy.
    Zihni AM; DeMeester SR
    Thorac Surg Clin; 2018 Nov; 28(4):465-472. PubMed ID: 30268292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Summaries for patients. Cost-effectiveness of screening and surveillance for Barrett esophagus.
    Ann Intern Med; 2003 Feb; 138(3):I-41. PubMed ID: 12558382
    [No Abstract]   [Full Text] [Related]  

  • 30. Endoscopy for Barrett's esophagus and esophageal adenocarcinoma.
    Shaheen N
    Am Fam Physician; 2004 May; 69(9):2060-1. PubMed ID: 15152951
    [No Abstract]   [Full Text] [Related]  

  • 31. Should we screen patients for Barrett's esophagus? Yes: men with long-standing reflux symptoms should be screened with endoscopy.
    Strayer SM
    Am Fam Physician; 2011 May; 83(10):1140, 1142, 1147. PubMed ID: 21568246
    [No Abstract]   [Full Text] [Related]  

  • 32. Barrett's Esophagus.
    Bujanda DE; Hachem C
    Mo Med; 2018; 115(3):211-213. PubMed ID: 30228724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving screening practices for Barrett's esophagus.
    Shaheen NJ; Palmer LB
    Surg Oncol Clin N Am; 2009 Jul; 18(3):423-37. PubMed ID: 19500734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of surveillance endoscopy, biopsy and biomarkers in early detection of Barrett's adenocarcinoma.
    Ellis FH; Loda M
    Dis Esophagus; 1997 Jul; 10(3):165-71. PubMed ID: 9280074
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnosing and managing Barrett's esophagus.
    Sampliner RE
    Am J Manag Care; 2000 Oct; 6(16 Suppl):S886-90. PubMed ID: 11184660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barrett's esophagus: is it all that bad?
    Tytgat GN
    Can J Gastroenterol; 1999 Jun; 13(5):385-8. PubMed ID: 10377467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esophageal adenocarcinoma and Barrett's esophagus.
    Sayana H; Wani S; Sharma P
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):157-69. PubMed ID: 17557044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ASGE guideline on screening and surveillance of Barrett's esophagus.
    ; Qumseya B; Sultan S; Bain P; Jamil L; Jacobson B; Anandasabapathy S; Agrawal D; Buxbaum JL; Fishman DS; Gurudu SR; Jue TL; Kripalani S; Lee JK; Khashab MA; Naveed M; Thosani NC; Yang J; DeWitt J; Wani S;
    Gastrointest Endosc; 2019 Sep; 90(3):335-359.e2. PubMed ID: 31439127
    [No Abstract]   [Full Text] [Related]  

  • 40. Are screening and surveillance for Barrett's oesophagus really worthwhile?
    Sharma P; Sidorenko EI
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i27-32. PubMed ID: 15711005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.